Press Releases

Washington, D.C., February 12, 2014 - Danaher Corporation (NYSE:DHR) announced that President and Chief Executive Officer, H. Lawrence Culp, Jr. will be presenting at the Barclays Industrial...

Danaher Corporation (NYSE: DHR), the "Company", today announced results for the fourth quarter and full year 2013. All financial metrics in this release reflect only the Company's continuing...

Washington, D.C., January 14, 2014 - Danaher Corporation (NYSE:DHR) announced that its President and Chief Executive Officer, H. Lawrence Culp, Jr., will comment tomorrow on the Company's fourth...

Washington, D.C., January 8, 2014 - Danaher Corporation (NYSE:DHR) announced that President and Chief Executive Officer, H. Lawrence Culp, Jr. will be presenting at the J.P. Morgan Healthcare...

Washington, D.C., January 7, 2014 - Danaher Corporation (NYSE:DHR) announced today that it will webcast its quarterly earnings conference call for the fourth quarter 2013 on Tuesday, January 28,...

Ahead of an institutional investor and analyst meeting to be held in New York, Danaher Corporation (NYSE: DHR) reaffirmed the Company's adjusted diluted net earnings per share guidance of $0.91 to...

Washington, D.C., December 10, 2013 - Danaher Corporation (NYSE:DHR) will host a live video webcast of its Annual Investor and Analyst Meeting on December 12, 2013 beginning at 1:15 p.m. EST and...

WASHINGTON, D.C., December 10, 2013 -- Danaher Corporation (NYSE:DHR) announced today that its Board of Directors has approved a regular quarterly dividend of $0.025 per share payable on January...

Washington, D.C., October 30, 2013 - Danaher Corporation (NYSE:DHR) announced that President and Chief Executive Officer, H. Lawrence Culp, Jr., will be presenting at the Robert W. Baird...

Danaher Corporation (NYSE: DHR) today announced results for the third quarter of 2013. All financial metrics in this release reflect only the Company's continuing operations and all references to...

Delivering the precision, clinical sensitivity and clinical specificity necessary to assist physicians with the diagnosis of myocardial infarction (MI), Beckman Coulter, Inc. announces the U.S....

Washington, D.C., September 17, 2013 - Danaher Corporation (NYSE:DHR) announced today that it will webcast its quarterly earnings conference call for the third quarter 2013 on Thursday, October...

WASHINGTON, D.C., September 10, 2013 -- Danaher Corporation (NYSE:DHR) announced today that its Board of Directors has approved a regular quarterly dividend of $0.025 per share payable on October...

Washington, D.C., September 9, 2013 - Danaher Corporation (NYSE:DHR) announced that Executive Vice President and Chief Financial Officer, Daniel L. Comas, will be presenting at the Morgan Stanley...

Danaher Corporation (NYSE: DHR) today announced results for the second quarter of 2013. All financial metrics in this release reflect only the Company's continuing operations unless otherwise...

WASHINGTON, D.C., July 9, 2013 - Danaher Corporation (NYSE:DHR) announced that it will comment today on the Company's second quarter 2013 financial performance in a presentation at its Investor...

WASHINGTON, D.C., July 2, 2013 -- Danaher Corporation (NYSE:DHR) will host a live video webcast of its Investor and Analyst Meeting on July 9, 2013 beginning at 1:00 p.m. CDT and concluding at...

Washington, D.C., June 18, 2013 - Danaher Corporation (NYSE:DHR) announced today that it will webcast its quarterly earnings conference call for the second quarter 2013 on Thursday, July 18, 2013...

Continuing its long history of proven clinical performance in diagnosis of myocardial infarction (MI), Beckman Coulter, Inc. announces the U.S. Food and Drug Administration (FDA) 510(k) clearance...

Washington, D.C., June 5, 2013 - Danaher Corporation (NYSE:DHR) announced that Executive Vice President and Chief Financial Officer, Daniel L. Comas, will be presenting at the Deutsche Bank Global...

Washington, D.C., May 28, 2012 - Danaher Corporation (NYSE:DHR) announced that Executive Vice President, Thomas P. Joyce, will be presenting at the Jefferies Global Healthcare Conference in New...

Washington, D.C., May 23, 2013 - Danaher Corporation (NYSE:DHR) announced that President and Chief Executive Officer, H. Lawrence Culp, Jr. will be presenting at the Sanford C. Bernstein Strategic...

Washington, D.C., May 13, 2013 - Danaher Corporation (NYSE:DHR) announced that President and Chief Executive Officer, H. Lawrence Culp, Jr. will be presenting at the Electrical Products Group...

WASHINGTON, D.C., May 7, 2013 -- Danaher Corporation (NYSE:DHR) announced today that its Board of Directors has approved a regular quarterly dividend of $0.025 per share payable on July 26, 2013...

Danaher Corporation (NYSE: DHR) today announced results for the first quarter of 2013. All financial metrics in this release reflect only the Company's continuing operations unless otherwise...